Maria Argos
Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arsenic | 48 | 2022 | 235 | 11.510 |
Why?
| Water Pollutants, Chemical | 22 | 2022 | 133 | 4.430 |
Why?
| Environmental Exposure | 30 | 2022 | 268 | 4.280 |
Why?
| Arsenic Poisoning | 15 | 2019 | 96 | 3.620 |
Why?
| Bangladesh | 53 | 2021 | 320 | 3.060 |
Why?
| Environmental Pollutants | 7 | 2022 | 45 | 2.770 |
Why?
| DNA Methylation | 9 | 2019 | 572 | 2.040 |
Why?
| Maternal Exposure | 6 | 2021 | 50 | 2.030 |
Why?
| Drinking Water | 9 | 2022 | 58 | 1.820 |
Why?
| Skin Diseases | 13 | 2019 | 163 | 1.810 |
Why?
| Diet | 8 | 2019 | 447 | 1.780 |
Why?
| Metals | 3 | 2018 | 90 | 1.650 |
Why?
| Occupational Exposure | 3 | 2018 | 75 | 1.500 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2021 | 144 | 1.430 |
Why?
| Polymorphism, Single Nucleotide | 20 | 2021 | 2328 | 1.410 |
Why?
| Pregnancy Outcome | 2 | 2020 | 272 | 1.310 |
Why?
| Cacodylic Acid | 4 | 2021 | 22 | 1.310 |
Why?
| Lung | 4 | 2021 | 1058 | 1.290 |
Why?
| Water Supply | 11 | 2022 | 60 | 1.280 |
Why?
| Vital Capacity | 4 | 2021 | 60 | 1.250 |
Why?
| Middle Aged | 71 | 2021 | 25586 | 1.240 |
Why?
| Female | 85 | 2022 | 44708 | 1.240 |
Why?
| Cohort Studies | 23 | 2021 | 2704 | 1.230 |
Why?
| Nutrition Surveys | 6 | 2022 | 90 | 1.220 |
Why?
| Groundwater | 2 | 2022 | 12 | 1.190 |
Why?
| Metals, Heavy | 3 | 2019 | 16 | 1.150 |
Why?
| Blood Pressure | 8 | 2020 | 1196 | 1.140 |
Why?
| Adult | 68 | 2021 | 25955 | 1.120 |
Why?
| Gene-Environment Interaction | 4 | 2018 | 101 | 1.090 |
Why?
| Humans | 104 | 2022 | 83081 | 1.090 |
Why?
| Asthma | 2 | 2021 | 878 | 1.050 |
Why?
| Hypertension | 5 | 2019 | 1207 | 1.040 |
Why?
| Male | 72 | 2021 | 41844 | 1.040 |
Why?
| Pesticides | 4 | 2020 | 25 | 1.020 |
Why?
| Epigenesis, Genetic | 4 | 2019 | 427 | 1.010 |
Why?
| Forced Expiratory Volume | 2 | 2021 | 114 | 0.970 |
Why?
| Genetic Predisposition to Disease | 14 | 2021 | 2216 | 0.960 |
Why?
| Cardiovascular Diseases | 9 | 2021 | 812 | 0.950 |
Why?
| Selenium | 3 | 2019 | 46 | 0.890 |
Why?
| Gravidity | 1 | 2020 | 6 | 0.880 |
Why?
| Prospective Studies | 25 | 2020 | 4067 | 0.870 |
Why?
| Environmental Monitoring | 6 | 2021 | 74 | 0.860 |
Why?
| Cross-Sectional Studies | 10 | 2021 | 1425 | 0.840 |
Why?
| Smoking | 8 | 2019 | 568 | 0.810 |
Why?
| Oligonucleotide Array Sequence Analysis | 6 | 2017 | 702 | 0.810 |
Why?
| Genome-Wide Association Study | 14 | 2021 | 1522 | 0.790 |
Why?
| Young Adult | 31 | 2021 | 5959 | 0.790 |
Why?
| Cardiotoxins | 1 | 2018 | 3 | 0.780 |
Why?
| Aged | 42 | 2021 | 18483 | 0.780 |
Why?
| Manganese | 1 | 2019 | 51 | 0.780 |
Why?
| Adolescent | 32 | 2021 | 9120 | 0.770 |
Why?
| Food | 3 | 2015 | 84 | 0.760 |
Why?
| Food Contamination | 5 | 2019 | 29 | 0.760 |
Why?
| Pregnancy | 8 | 2022 | 2809 | 0.740 |
Why?
| Residence Characteristics | 1 | 2020 | 211 | 0.730 |
Why?
| Child Mortality | 1 | 2017 | 5 | 0.710 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 15 | 0.710 |
Why?
| Telomere | 4 | 2021 | 96 | 0.700 |
Why?
| Urinalysis | 1 | 2017 | 50 | 0.690 |
Why?
| Solvents | 1 | 2017 | 103 | 0.690 |
Why?
| Risk Factors | 19 | 2021 | 5401 | 0.670 |
Why?
| Diet, Gluten-Free | 1 | 2017 | 50 | 0.660 |
Why?
| Obesity | 3 | 2021 | 966 | 0.650 |
Why?
| Birth Weight | 3 | 2022 | 148 | 0.650 |
Why?
| Arsenicals | 5 | 2019 | 42 | 0.640 |
Why?
| Longitudinal Studies | 16 | 2020 | 971 | 0.630 |
Why?
| Antioxidants | 3 | 2013 | 231 | 0.620 |
Why?
| Carcinogens | 1 | 2016 | 109 | 0.620 |
Why?
| Selenomethionine | 2 | 2013 | 11 | 0.610 |
Why?
| Lung Diseases | 2 | 2016 | 268 | 0.600 |
Why?
| Child | 9 | 2021 | 6721 | 0.600 |
Why?
| Proportional Hazards Models | 6 | 2020 | 870 | 0.600 |
Why?
| Telomere Homeostasis | 3 | 2021 | 30 | 0.590 |
Why?
| Skin Neoplasms | 4 | 2019 | 538 | 0.580 |
Why?
| Quantitative Trait Loci | 5 | 2021 | 556 | 0.560 |
Why?
| Mendelian Randomization Analysis | 3 | 2021 | 41 | 0.550 |
Why?
| CpG Islands | 5 | 2019 | 139 | 0.550 |
Why?
| Breast Neoplasms | 8 | 2019 | 2775 | 0.540 |
Why?
| Water Wells | 4 | 2022 | 19 | 0.540 |
Why?
| Digestive System Neoplasms | 1 | 2013 | 22 | 0.530 |
Why?
| alpha-Tocopherol | 1 | 2013 | 10 | 0.530 |
Why?
| Gene Expression | 2 | 2018 | 1332 | 0.520 |
Why?
| United States | 9 | 2022 | 6296 | 0.510 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2019 | 1279 | 0.500 |
Why?
| Anticarcinogenic Agents | 1 | 2013 | 73 | 0.500 |
Why?
| Methyltransferases | 3 | 2019 | 171 | 0.480 |
Why?
| Water Pollution, Chemical | 3 | 2011 | 21 | 0.480 |
Why?
| Body Mass Index | 8 | 2018 | 783 | 0.460 |
Why?
| Genome, Human | 5 | 2019 | 752 | 0.450 |
Why?
| Vitamin B Complex | 1 | 2010 | 22 | 0.420 |
Why?
| Ammonia-Lyases | 2 | 2019 | 6 | 0.400 |
Why?
| Glutamate Formimidoyltransferase | 2 | 2019 | 6 | 0.400 |
Why?
| Gestational Age | 2 | 2021 | 319 | 0.400 |
Why?
| Prevalence | 7 | 2018 | 1261 | 0.390 |
Why?
| Genotype | 8 | 2019 | 1853 | 0.380 |
Why?
| Infant | 3 | 2021 | 3085 | 0.370 |
Why?
| Genetic Variation | 4 | 2021 | 1357 | 0.370 |
Why?
| Genotyping Techniques | 3 | 2019 | 65 | 0.370 |
Why?
| African Americans | 3 | 2021 | 1168 | 0.370 |
Why?
| Loss of Heterozygosity | 1 | 2008 | 87 | 0.360 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 1207 | 0.360 |
Why?
| Phenotype | 8 | 2021 | 2285 | 0.360 |
Why?
| Infant, Newborn | 4 | 2020 | 2430 | 0.350 |
Why?
| Gene Amplification | 1 | 2008 | 134 | 0.350 |
Why?
| Parity | 2 | 2020 | 97 | 0.350 |
Why?
| Chicago | 3 | 2021 | 1446 | 0.350 |
Why?
| Gene Expression Regulation | 4 | 2018 | 1936 | 0.330 |
Why?
| Mortality | 3 | 2017 | 148 | 0.330 |
Why?
| Social Class | 1 | 2007 | 134 | 0.320 |
Why?
| Odds Ratio | 6 | 2019 | 683 | 0.320 |
Why?
| Chromosome Aberrations | 1 | 2008 | 397 | 0.320 |
Why?
| Public Health | 2 | 2021 | 107 | 0.320 |
Why?
| Gene Expression Profiling | 4 | 2014 | 1367 | 0.310 |
Why?
| Leukocytes | 2 | 2018 | 194 | 0.310 |
Why?
| Prostatic Neoplasms | 1 | 2016 | 1467 | 0.310 |
Why?
| Smoking Cessation | 2 | 2019 | 177 | 0.280 |
Why?
| Sex Factors | 4 | 2018 | 1091 | 0.270 |
Why?
| Lymphocytes | 1 | 2006 | 475 | 0.270 |
Why?
| Socioeconomic Factors | 2 | 2018 | 579 | 0.240 |
Why?
| Neoplasms | 3 | 2014 | 2672 | 0.240 |
Why?
| Thinness | 2 | 2014 | 38 | 0.240 |
Why?
| Child, Preschool | 3 | 2021 | 3752 | 0.240 |
Why?
| Precancerous Conditions | 3 | 2010 | 206 | 0.240 |
Why?
| Respiration Disorders | 2 | 2013 | 42 | 0.230 |
Why?
| Blood Cells | 1 | 2021 | 36 | 0.230 |
Why?
| Telomere Shortening | 1 | 2021 | 24 | 0.230 |
Why?
| Databases, Genetic | 3 | 2019 | 259 | 0.220 |
Why?
| Regression Analysis | 4 | 2017 | 624 | 0.220 |
Why?
| Incidence | 5 | 2018 | 1638 | 0.220 |
Why?
| Aging | 2 | 2019 | 666 | 0.220 |
Why?
| Water Purification | 1 | 2020 | 4 | 0.210 |
Why?
| beta-Globins | 1 | 2019 | 2 | 0.210 |
Why?
| Life Style | 2 | 2018 | 189 | 0.210 |
Why?
| Cadmium | 2 | 2019 | 29 | 0.200 |
Why?
| Blood | 1 | 2019 | 74 | 0.200 |
Why?
| Receptor, EphA4 | 1 | 2019 | 6 | 0.200 |
Why?
| Genes, Mitochondrial | 1 | 2018 | 9 | 0.200 |
Why?
| Air Pollution | 1 | 2019 | 37 | 0.200 |
Why?
| Acculturation | 1 | 2018 | 16 | 0.190 |
Why?
| Metabolism | 1 | 2018 | 25 | 0.190 |
Why?
| Receptors, Opioid | 1 | 2019 | 27 | 0.190 |
Why?
| Ions | 1 | 2019 | 73 | 0.190 |
Why?
| Case-Control Studies | 6 | 2018 | 1825 | 0.190 |
Why?
| Air Pollutants | 1 | 2019 | 50 | 0.190 |
Why?
| Exercise | 2 | 2021 | 279 | 0.190 |
Why?
| Aged, 80 and over | 6 | 2020 | 6577 | 0.180 |
Why?
| DNA, Mitochondrial | 1 | 2018 | 182 | 0.180 |
Why?
| Obesity, Abdominal | 1 | 2017 | 7 | 0.180 |
Why?
| Atlases as Topic | 1 | 2017 | 6 | 0.180 |
Why?
| Muscle Contraction | 1 | 2019 | 306 | 0.180 |
Why?
| Stillbirth | 1 | 2017 | 7 | 0.180 |
Why?
| Abortion, Therapeutic | 1 | 2017 | 11 | 0.180 |
Why?
| Muscle, Smooth, Vascular | 1 | 2019 | 247 | 0.180 |
Why?
| Epistasis, Genetic | 1 | 2018 | 86 | 0.170 |
Why?
| Lipoproteins, LDL | 1 | 2017 | 112 | 0.170 |
Why?
| Naltrexone | 1 | 2019 | 125 | 0.170 |
Why?
| DNA Helicases | 1 | 2017 | 64 | 0.170 |
Why?
| Chromosomes, Human | 1 | 2017 | 69 | 0.170 |
Why?
| Narcotic Antagonists | 1 | 2019 | 150 | 0.170 |
Why?
| Abortion, Spontaneous | 1 | 2017 | 60 | 0.170 |
Why?
| Transcriptome | 1 | 2021 | 508 | 0.170 |
Why?
| Drinking | 3 | 2011 | 39 | 0.170 |
Why?
| Triglycerides | 1 | 2017 | 319 | 0.160 |
Why?
| Depressive Disorder | 1 | 2017 | 220 | 0.160 |
Why?
| Creatinine | 1 | 2017 | 347 | 0.160 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 177 | 0.160 |
Why?
| Dyslipidemias | 1 | 2017 | 120 | 0.160 |
Why?
| Self Report | 1 | 2017 | 262 | 0.160 |
Why?
| Parents | 1 | 2018 | 252 | 0.160 |
Why?
| Age Factors | 2 | 2018 | 1913 | 0.160 |
Why?
| Areca | 2 | 2013 | 9 | 0.160 |
Why?
| Lead | 1 | 2015 | 22 | 0.150 |
Why?
| Dyspnea | 1 | 2016 | 80 | 0.150 |
Why?
| Anxiety Disorders | 1 | 2016 | 117 | 0.150 |
Why?
| Gonadal Steroid Hormones | 1 | 2015 | 54 | 0.150 |
Why?
| Heart Diseases | 2 | 2016 | 314 | 0.150 |
Why?
| Proteinuria | 1 | 2015 | 114 | 0.140 |
Why?
| Fetal Blood | 1 | 2015 | 99 | 0.140 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2015 | 66 | 0.140 |
Why?
| Mitochondria | 1 | 2018 | 532 | 0.140 |
Why?
| Developing Countries | 1 | 2015 | 73 | 0.140 |
Why?
| Follow-Up Studies | 4 | 2018 | 3877 | 0.140 |
Why?
| Illinois | 1 | 2016 | 463 | 0.140 |
Why?
| Atrial Fibrillation | 1 | 2018 | 267 | 0.140 |
Why?
| Germ-Line Mutation | 1 | 2017 | 290 | 0.140 |
Why?
| Phosphofructokinase-1, Muscle Type | 1 | 2014 | 9 | 0.140 |
Why?
| Chondromatosis | 1 | 1993 | 2 | 0.140 |
Why?
| Leiomyoma, Epithelioid | 1 | 1993 | 2 | 0.140 |
Why?
| Paraganglioma, Extra-Adrenal | 1 | 1993 | 12 | 0.140 |
Why?
| Dose-Response Relationship, Drug | 4 | 2013 | 2100 | 0.140 |
Why?
| Anxiety | 1 | 2016 | 257 | 0.140 |
Why?
| Depression | 1 | 2017 | 415 | 0.140 |
Why?
| Multifactorial Inheritance | 1 | 2015 | 127 | 0.130 |
Why?
| Mediastinal Neoplasms | 1 | 1993 | 48 | 0.130 |
Why?
| Arm | 1 | 2014 | 97 | 0.130 |
Why?
| Urinary Bladder | 1 | 2015 | 175 | 0.130 |
Why?
| Neoplasms, Multiple Primary | 1 | 1993 | 108 | 0.130 |
Why?
| Overweight | 1 | 2014 | 111 | 0.130 |
Why?
| Keratosis | 1 | 2012 | 22 | 0.130 |
Why?
| Vitamin E | 2 | 2014 | 42 | 0.130 |
Why?
| Cell Transformation, Neoplastic | 1 | 2015 | 410 | 0.120 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2012 | 48 | 0.120 |
Why?
| Gene Regulatory Networks | 1 | 2014 | 279 | 0.120 |
Why?
| Models, Statistical | 1 | 2016 | 580 | 0.120 |
Why?
| Alleles | 4 | 2019 | 1115 | 0.120 |
Why?
| Urinary Bladder Neoplasms | 1 | 2015 | 329 | 0.110 |
Why?
| Tremor | 1 | 2011 | 21 | 0.110 |
Why?
| Essential Tremor | 1 | 2011 | 7 | 0.110 |
Why?
| Methylation | 3 | 2019 | 240 | 0.110 |
Why?
| Tissue Fixation | 1 | 2010 | 37 | 0.110 |
Why?
| Formaldehyde | 1 | 2010 | 50 | 0.110 |
Why?
| Paraffin Embedding | 1 | 2010 | 77 | 0.110 |
Why?
| Stomach Neoplasms | 1 | 1993 | 262 | 0.110 |
Why?
| Double-Blind Method | 2 | 2013 | 1899 | 0.110 |
Why?
| Skin | 1 | 2014 | 560 | 0.110 |
Why?
| Protective Agents | 1 | 2010 | 32 | 0.110 |
Why?
| MicroRNAs | 1 | 2015 | 508 | 0.100 |
Why?
| Water | 1 | 2011 | 261 | 0.100 |
Why?
| Health Surveys | 2 | 2011 | 248 | 0.100 |
Why?
| Population Surveillance | 1 | 2011 | 241 | 0.100 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2008 | 45 | 0.090 |
Why?
| DNA | 1 | 2014 | 1300 | 0.090 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2008 | 81 | 0.090 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2008 | 85 | 0.090 |
Why?
| Protein Carbonylation | 1 | 2008 | 10 | 0.090 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2008 | 103 | 0.090 |
Why?
| Ownership | 1 | 2007 | 19 | 0.090 |
Why?
| Gene Dosage | 1 | 2008 | 216 | 0.090 |
Why?
| Rural Population | 3 | 2014 | 121 | 0.090 |
Why?
| Gene Frequency | 2 | 2019 | 669 | 0.080 |
Why?
| Sex Characteristics | 2 | 2019 | 309 | 0.080 |
Why?
| Chronic Disease | 1 | 2010 | 964 | 0.080 |
Why?
| Population Groups | 1 | 2006 | 42 | 0.080 |
Why?
| Cause of Death | 3 | 2013 | 272 | 0.080 |
Why?
| Risk Assessment | 3 | 2018 | 2278 | 0.070 |
Why?
| Chromosome Mapping | 1 | 2008 | 1100 | 0.070 |
Why?
| Computer Simulation | 2 | 2022 | 1058 | 0.070 |
Why?
| Vegetables | 2 | 2015 | 41 | 0.060 |
Why?
| Demography | 2 | 2015 | 162 | 0.060 |
Why?
| Age of Onset | 2 | 2017 | 320 | 0.060 |
Why?
| Research Design | 1 | 2006 | 566 | 0.060 |
Why?
| Lung Neoplasms | 1 | 1993 | 2116 | 0.060 |
Why?
| Animals | 2 | 2019 | 26937 | 0.060 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 525 | 0.050 |
Why?
| Michigan | 1 | 2020 | 56 | 0.050 |
Why?
| Waist-Hip Ratio | 1 | 2018 | 22 | 0.050 |
Why?
| Folic Acid | 1 | 2019 | 45 | 0.050 |
Why?
| Myocytes, Smooth Muscle | 1 | 2019 | 132 | 0.050 |
Why?
| Health Education | 1 | 2019 | 104 | 0.050 |
Why?
| Estrogens | 1 | 2019 | 190 | 0.050 |
Why?
| Linkage Disequilibrium | 1 | 2019 | 482 | 0.050 |
Why?
| Glutathione Transferase | 1 | 2018 | 113 | 0.040 |
Why?
| Adipocytes | 1 | 2018 | 156 | 0.040 |
Why?
| Adiposity | 1 | 2017 | 72 | 0.040 |
Why?
| Longevity | 1 | 2017 | 47 | 0.040 |
Why?
| Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
| Breast | 1 | 2019 | 278 | 0.040 |
Why?
| Receptors, Progesterone | 1 | 2018 | 166 | 0.040 |
Why?
| RNA, Small Interfering | 1 | 2019 | 568 | 0.040 |
Why?
| Genetics, Population | 1 | 2019 | 377 | 0.040 |
Why?
| Mutation | 1 | 2008 | 3853 | 0.040 |
Why?
| Receptors, Estrogen | 1 | 2018 | 382 | 0.040 |
Why?
| Computational Biology | 1 | 2019 | 529 | 0.040 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2015 | 21 | 0.040 |
Why?
| Glucose | 1 | 2018 | 624 | 0.040 |
Why?
| Time Factors | 2 | 2015 | 5497 | 0.040 |
Why?
| Fruit | 1 | 2015 | 71 | 0.040 |
Why?
| Asia | 1 | 2014 | 92 | 0.040 |
Why?
| Chemoprevention | 1 | 2014 | 90 | 0.040 |
Why?
| Immunoenzyme Techniques | 1 | 2015 | 329 | 0.040 |
Why?
| Data Collection | 2 | 2006 | 369 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 942 | 0.030 |
Why?
| Comorbidity | 1 | 2018 | 937 | 0.030 |
Why?
| PTEN Phosphohydrolase | 1 | 2015 | 121 | 0.030 |
Why?
| Causality | 1 | 2013 | 80 | 0.030 |
Why?
| Spectrophotometry, Atomic | 1 | 2013 | 14 | 0.030 |
Why?
| Poverty | 1 | 2015 | 168 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 286 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2015 | 177 | 0.030 |
Why?
| Inflammation | 1 | 2019 | 821 | 0.030 |
Why?
| Respiratory Function Tests | 1 | 2013 | 147 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2015 | 305 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 1470 | 0.030 |
Why?
| Organ Size | 1 | 2014 | 381 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2016 | 900 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 531 | 0.030 |
Why?
| Insulin | 1 | 2018 | 1169 | 0.030 |
Why?
| Survival Analysis | 1 | 2017 | 1585 | 0.030 |
Why?
| Syndrome | 1 | 1993 | 434 | 0.030 |
Why?
| Blotting, Western | 1 | 2015 | 831 | 0.030 |
Why?
| Mass Spectrometry | 1 | 2013 | 182 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 923 | 0.030 |
Why?
| Tobacco, Smokeless | 1 | 2011 | 10 | 0.030 |
Why?
| Genomics | 1 | 2018 | 643 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 321 | 0.030 |
Why?
| Food Analysis | 1 | 2011 | 5 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 3176 | 0.030 |
Why?
| Diabetes Mellitus | 1 | 2018 | 755 | 0.030 |
Why?
| Community Health Planning | 1 | 2011 | 16 | 0.030 |
Why?
| Polymorphism, Genetic | 1 | 2015 | 821 | 0.030 |
Why?
| Cucurbitaceae | 1 | 2010 | 4 | 0.030 |
Why?
| Mastication | 1 | 2011 | 67 | 0.030 |
Why?
| Fertilizers | 1 | 2010 | 8 | 0.030 |
Why?
| Sunlight | 1 | 2010 | 30 | 0.030 |
Why?
| Genes, Neoplasm | 1 | 2010 | 38 | 0.030 |
Why?
| Cell Movement | 1 | 2015 | 743 | 0.030 |
Why?
| Interviews as Topic | 1 | 2011 | 331 | 0.030 |
Why?
| Epidemiologic Methods | 1 | 2010 | 65 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 326 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2010 | 153 | 0.030 |
Why?
| Organ Specificity | 1 | 2010 | 260 | 0.030 |
Why?
| Prognosis | 1 | 2018 | 3698 | 0.030 |
Why?
| Cluster Analysis | 1 | 2010 | 373 | 0.020 |
Why?
| Respiratory Tract Diseases | 1 | 2009 | 44 | 0.020 |
Why?
| Down-Regulation | 1 | 2010 | 520 | 0.020 |
Why?
| Cells, Cultured | 1 | 2015 | 2969 | 0.020 |
Why?
| Intelligence | 1 | 2009 | 72 | 0.020 |
Why?
| RNA, Messenger | 1 | 2015 | 1992 | 0.020 |
Why?
| Cell Proliferation | 1 | 2015 | 1611 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 962 | 0.020 |
Why?
| Nervous System Diseases | 1 | 2009 | 150 | 0.020 |
Why?
| Appendicitis | 1 | 1988 | 54 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 712 | 0.020 |
Why?
| Signal Transduction | 1 | 2019 | 3297 | 0.020 |
Why?
| Apoptosis | 1 | 2015 | 1774 | 0.020 |
Why?
| Dietary Supplements | 1 | 2008 | 137 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2008 | 379 | 0.020 |
Why?
| Leukocytes, Mononuclear | 1 | 2007 | 191 | 0.020 |
Why?
| Treatment Outcome | 1 | 2019 | 7886 | 0.020 |
Why?
| Haplotypes | 1 | 2008 | 642 | 0.020 |
Why?
| Pilot Projects | 1 | 2008 | 832 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2008 | 990 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2011 | 1777 | 0.020 |
Why?
| Proteins | 1 | 2010 | 782 | 0.020 |
Why?
| Mice | 1 | 2019 | 11119 | 0.020 |
Why?
| Risk | 1 | 2006 | 700 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2010 | 2666 | 0.020 |
Why?
| RNA | 1 | 2007 | 511 | 0.020 |
Why?
| Retrospective Studies | 2 | 2011 | 7599 | 0.010 |
Why?
| False Negative Reactions | 1 | 1988 | 68 | 0.010 |
Why?
| False Positive Reactions | 1 | 1988 | 224 | 0.010 |
Why?
| Acute Disease | 1 | 1988 | 864 | 0.000 |
Why?
| Ultrasonography | 1 | 1988 | 693 | 0.000 |
Why?
|
|
Argos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|